Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) CEO Henry O. Gosebruch purchased 15,000 shares of the business’s stock in a transaction dated Tuesday, September 19th. The shares were purchased at an average price of $12.62 per share, with a total value of $189,300.00. Following the purchase, the chief executive officer now directly owns 15,000 […]